![Philip Vickers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip Vickers
Director Ejecutivo en Solu Therapeutics .
Fortuna: 7 104 $ al 31/05/2024
Cargos activos de Philip Vickers
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Northern Mosaic LP
![]() Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Director/Miembro de la Junta | - | - |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Director Ejecutivo | - | - |
Presidente | - | - |
Historial de carrera de Philip Vickers
Antiguos cargos conocidos de Philip Vickers.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TECTONIC THERAPEUTIC, INC. | Director/Miembro de la Junta | 07/01/2019 | 20/05/2024 |
Independent Dir/Board Member | 07/01/2019 | 20/05/2024 | |
REVANCE THERAPEUTICS, INC. | Director/Miembro de la Junta | 26/02/2015 | 03/05/2023 |
Independent Dir/Board Member | 26/02/2015 | 03/05/2023 | |
Faze Medicines, Inc. /MA)
![]() Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | Director/Miembro de la Junta | 01/01/2021 | 01/11/2022 |
Director Ejecutivo | 01/01/2021 | 01/11/2022 | |
Presidente | 01/01/2021 | 01/11/2022 | |
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Director/Miembro de la Junta | 13/11/2017 | 01/12/2020 |
Director Ejecutivo | 13/11/2017 | 01/12/2020 | |
Presidente | 13/11/2017 | 01/12/2020 | |
SHIRE | Director Técnico/Científico/I+D | 01/10/2010 | 01/06/2017 |
Resolvyx Pharmaceuticals, Inc.
![]() Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 16/04/2009 | 01/01/2011 |
Director Técnico/Científico/I+D | 16/04/2009 | 01/01/2011 | |
Presidente | 01/01/2009 | 01/01/2011 | |
Neusentis Ltd.
![]() Neusentis Ltd. Miscellaneous Commercial ServicesCommercial Services Neusentis Ltd. engages in other business support service activities. The company was founded on October 2, 1997 and is headquartered in Sandwich, the United Kingdom. | Director/Miembro de la Junta | - | - |
░░░░░░ ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de Philip Vickers.
University of Toronto | Doctorate Degree |
University of Salford | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Canadá | 4 |
Reino Unido | 3 |
Operativa
Director/Board Member | 7 |
President | 4 |
Corporate Officer/Principal | 3 |
Sectorial
Health Technology | 9 |
Commercial Services | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 11 |
---|---|
Resolvyx Pharmaceuticals, Inc.
![]() Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Pfizer (St. Louis)
![]() Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
Neusentis Ltd.
![]() Neusentis Ltd. Miscellaneous Commercial ServicesCommercial Services Neusentis Ltd. engages in other business support service activities. The company was founded on October 2, 1997 and is headquartered in Sandwich, the United Kingdom. | Commercial Services |
Shire Plc
![]() Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Northern Mosaic LP
![]() Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Commercial Services |
Faze Medicines, Inc. /MA)
![]() Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | Commercial Services |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Health Technology |
- Bolsa de valores
- Insiders
- Philip Vickers
- Experiencia